Sertraline treatment of interferon-alfa-induced depressive disorder


Autoria(s): Schramm, T. M.; Lawford, B.; Macdonald, G. A.; Cooksley, W. G. E.
Data(s)

02/10/2000

Resumo

Interferon alfa therapy for chronic hepatitis C infection is commonly associated with neuropsychiatric symptoms, including depression. These side effects may necessitate reduction or even cessation of interferon alfa, hut there is little information regarding the management of this important problem. We report 10 cases of interferon-alfa-induced depressive disorder treated with the selective serotonin reuptake inhibitor sertraline. All patients obtained rapid symptom relief without the need for reduction or cessation of interferon alfa.

Identificador

http://espace.library.uq.edu.au/view/UQ:36790

Idioma(s)

eng

Publicador

Australasian Medical Publishing

Palavras-Chave #Medicine, General & Internal #Trial Comparing Sertraline #Chronic Hepatitis-c #Alpha #Therapy #Tryptophan #Serotonin #Disease #States #Virus #Mood #320000 Medical and Health Sciences
Tipo

Journal Article